GUANGZHOU 8TH PEOPLES HOSPITAL has a total of 18 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are YI JINYANG, INNAVIRVAX and MULTIVIR INC.
Traditional Chinese medicine composition for treating herpes zoster, application of traditional Chinese medicine composition in external medicament and preparation method
CN111705080A
Construction method and application of HBV non-human animal model
CN111424101A
Kit and method for quantitatively detecting yersinia sporogenes
CN111345933A
Medical plane restraint belting
CN111265616A
Traditional Chinese medicine composition and application thereof in prevention and treatment of viral pneumonia
CN110279823A
A kind of Chinese medicine composition and preparation method thereof for treating dengue fever
CN110669735A
System for inducing formation of HBV cccDNA and construction method
CN109998778A
A kind of band pressure medical application suit
CN109985180A
A kind of Traditional Chinese medicine compound composition is preparing the purposes in anti-hepatic fibrosis medicines
CN109503712A
A kind of monoclonal antibody ZKns2E11 and its application
CN109553680A
A kind of monoclonal antibody ZKns4B8 and its application
CN109535249A
A kind of monoclonal antibody ZKns3G2 and its application
CN109160942A
The peptide fragment 502-518 and application thereof in the highly conserved region of HCV envelope protein
CN109232721A
The peptide fragment 418-429 and application thereof in the highly conserved region of HCV envelope protein
CN109232722A
The peptide fragment 317-325 and application thereof in the highly conserved region of HCV envelope protein
CN107475444A
A kind of selective amplification RNA PCR primer, kit and method in total nucleic acid from hepatitis type B virus
CN108727491A
A kind of monoclonal antibody ZK7C3 and application
CN108727489A
A kind of monoclonal antibody ZK2C2 and application
